HOME
LOGIN
THE MEDICAL LETTER
Subscribe
Current Issue
Previous Issues
Reference Tables
Sample Articles
ABOUT US
The Medical Letter, Inc.
CONTINUING EDUCATION
Exams
DRUG INTERACTIONS
PRODUCTS
CONTACT US
The Medical Letter Mobile Home Page
CURRENT
ISSUE
1622
The choice of drugs for treatment of allergic rhinitis depends on the severity of symptoms and whether they are are intermittent or persistent (see Table 1).  read more...
More from issue 1622
Advance Release
Coming Soon
Vibegron (Gemtesa) for Overactive Bladder
Fluvoxamine for COVID-19?
Evinacumab (Evkeeza) for Homozygous Familial Hypercholesterolemia
Tirbanibulin (Klisyri) for Actinic Keratosis
Recommend to Your Library  
Previous Issues
© 2021 The Medical Letter, Inc.